Christine D. Baker's most recent trade in Hookipa Pharma Inc was a trade of 275,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hookipa Pharma Inc | Christine D. Baker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 275,800 | 275,800 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Christine D. Baker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Christine D. Baker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Christine D. Baker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 22,763 | 22,763 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Christine D. Baker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 01 Feb 2022 | 13,658 | 16,158 (0%) | 0% | 3 | 40,974 | Common Stock |
| Hookipa Pharma Inc | Christine D. Baker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 49,950 | 49,950 | - | - | Stock Option (Right to Buy) |